| |
| |
|
| Insider
Information: |
Divis Greg J |
| Relationship: |
Director |
| City: |
St. Louis |
| State: |
MO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
171,233 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,545,037 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
171,233 |
|
|
| Total
Value |
$2,545,037 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 80.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
KV Pharmaceutical Co |
KVPHQ |
CEO and President, Dir... |
2013-09-16 |
0 |
2008-07-18 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
Chief Executive Office... |
2023-08-10 |
159,100 |
2017-09-12 |
0 |
Premium* |
|
|
Jaguar Health Inc |
JAGX |
Director |
2022-05-18 |
12,133 |
2022-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVDL |
AVADEL Pharmaceuticals Pl... |
Chief Executive Officer |
• • – |
2023-08-10 |
4 |
B |
$13.20 |
$131,997 |
D/D |
10,000 |
159,100 |
2.81 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Chief Executive Officer |
• • – |
2022-05-27 |
4 |
B |
$2.05 |
$102,500 |
D/D |
50,000 |
149,100 |
2.81 |
% |
|
| JAGX |
Jaguar Health Inc |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,133 |
12,133 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Chief Executive Officer |
• • – |
2020-08-12 |
4 |
B |
$7.78 |
$101,156 |
D/D |
13,000 |
99,100 |
2.81 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Chief Executive Officer |
• – – |
2019-11-15 |
4 |
B |
$5.13 |
$97,470 |
D/D |
19,000 |
86,100 |
2.74 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
See Remarks |
• – – |
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
67,100 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
See Remarks |
• – – |
2018-06-26 |
4 |
B |
$6.00 |
$96,000 |
D/D |
16,000 |
49,100 |
2.74 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
See Remarks |
• – – |
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
33,100 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
See Remarks |
• – – |
2017-09-12 |
4 |
B |
$9.32 |
$98,760 |
D/D |
10,600 |
10,600 |
2.74 |
- |
|
| KVPHQ |
KV Pharmaceutical Co |
CEO and President |
• • – |
2013-09-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,225) |
0 |
0 |
- |
|
| KVPHQ |
KV Pharmaceutical Co |
President, Ther-Rx Corporation |
• – – |
2008-07-18 |
4 |
OE |
$28.60 |
$35,035 |
D/D |
1,225 |
1,225 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
